NHS Framework Agreement for the supply of Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema

NHS England

This public procurement record has 2 releases in its history.

Award

16 Jul 2018 at 14:15

Tender

27 Feb 2018 at 12:26

Summary of the contracting process

The NHS England is procuring a framework agreement for the supply of Icatibant and C1 Esterase products aimed at treating Hereditary Angioedema. This procurement, classified under pharmaceutical products, is valued at £72 million and will run from 1st July 2018 to 30th June 2019, with an option to extend for up to 36 months. The tender process was conducted using an open procedure, and the deadline for submissions was 29th March 2018.

This contract offers significant opportunities for businesses, particularly small and medium-sized enterprises (SMEs) that supply healthcare and pharmaceutical products. Companies that specialise in innovative treatments or have a background in supplying the NHS and related health services would be particularly well-positioned to compete for this framework. Success in this tender can facilitate expansion into the public healthcare sector and establish long-term relationships with key stakeholders in the NHS.

How relevant is this notice?

Notice Title

NHS Framework Agreement for the supply of Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema

Notice Description

NHS Framework Agreement for the supply of Icatibant and C1-Esterase products for the treatment of Hereditary Angioedema. The framework will commence on 1st July 2018 for a period of 12 months until 30th June 2019, with options to extend up to a further 36 months.

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-1d6a380a-446a-4d72-ac49-db35a20e38a5
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/7400eba6-8e62-4241-879e-a0c574ef4408
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£72,000,000 £10M-£100M
Lots Value
Not specified
Awards Value
£72,000,000 £10M-£100M
Contracts Value
Not specified

Notice Dates

Publication Date
16 Jul 20188 years ago
Submission Deadline
29 Mar 2018Expired
Future Notice Date
Not specified
Award Date
20 Jun 20188 years ago
Contract Period
1 Jul 2018 - 30 Jun 2019 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England

Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLL Wales, TLM Scotland, TLN Northern Ireland

Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
3
Supplier Names

Shire Pharmaceuticals Limited

CSL Behring UK Ltd

Pharming Technologies NV

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...